BRIEF published on 03/19/2026 at 08:05, 19 days 1 hour ago OHB SE affiche une forte croissance dans ses résultats financiers de 2025 Croissance Financière SYSTÈMES SPATIAUX Prise De Commande Investissements Européens Extension OHB
BRIEF published on 03/19/2026 at 07:55, 19 days 1 hour ago AFYREN Achieves ISO 9001 Certification for AFYREN NEOXY Plant Sustainability Certification Quality Management AFYREN ISO 9001
BRIEF published on 03/19/2026 at 07:55, 19 days 1 hour ago AFYREN obtient la certification ISO 9001 pour son usine AFYREN NEOXY Certification Durabilité Gestion De La Qualité AFYREN ISO 9001
BRIEF published on 03/19/2026 at 07:40, 19 days 2 hours ago Lenzing Reports 2025 Financial Outcomes Amid Transformation Efforts Market Challenges Lenzing AG Cost Savings EBITDA Growth 2025 Financial Results
BRIEF published on 03/19/2026 at 07:40, 19 days 2 hours ago Lenzing publie ses résultats financiers pour 2025 dans un contexte de transformation. Lenzing AG Réduction Des Coûts Défis Du Marché Croissance De L'EBITDA Résultats Financiers 2025
BRIEF published on 03/19/2026 at 07:35, 19 days 2 hours ago AL-S Pharma's AP-101 Shows Promise in ALS Treatment Clinical Trial ALS Treatment Phase 2 Data AP-101 SOD1 Targeting
BRIEF published on 03/19/2026 at 07:35, 19 days 2 hours ago Le traitement AP-101 d'AL-S Pharma se révèle prometteur dans le traitement de la SLA. Essai Clinique Traitement De La SLA Données De La Phase 2 AP-101 Ciblage SOD1
BRIEF published on 03/19/2026 at 07:35, 19 days 2 hours ago Nordex Group Secures 54 MW Orders from Prowind in Germany Renewable Energy Germany Wind Turbines Nordex Prowind
BRIEF published on 03/19/2026 at 07:35, 19 days 2 hours ago Le groupe Nordex décroche une commande de 54 MW auprès de Prowind en Allemagne. Énergie Renouvelable Allemagne Éoliennes Nordex Prowind
BRIEF published on 03/19/2026 at 07:35, 19 days 2 hours ago Evotec Achieves $10M Milestone in Collaboration with Bristol Myers Squibb Cancer Treatment Clinical Trial Evotec Bristol Myers Squibb Molecular Glues
Published on 04/07/2026 at 09:30, 16 minutes ago Formation Metals to Host Live Investor Webinar on the N2 Gold Project to Discuss Phase 1 Drill Results, including 1.75 g/t Au over 30.4 Metres, and Maiden Resource Estimate Following Fully Funded 30,000-Metre Program
Published on 04/07/2026 at 09:05, 41 minutes ago BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
Published on 04/07/2026 at 09:01, 45 minutes ago Apex Drills 81.6 m of 2.02% REO, including 50.9 m of 2.40% REO, Extending Strike Length of Main Body, with Highly Enriched NdPr Zone at Rift
Published on 04/07/2026 at 08:00, 1 hour 46 minutes ago Caledonia Mining Corporation Plc: Encouraging Results From Deep Level Drilling at Blanket Mine
Published on 04/07/2026 at 00:02, 9 hours 44 minutes ago Evergold Announces Closing of $5.4 Million Non-Brokered Private Placement
Published on 04/07/2026 at 09:13, 33 minutes ago Apprenticeship 2026: Entry-level salaries reflect economic change
Published on 04/07/2026 at 09:11, 35 minutes ago Huge land holdings, promising drill results: An exciting new gold story is unfolding in Liberia
Published on 04/07/2026 at 09:00, 46 minutes ago Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 04/07/2026 at 08:30, 1 hour 16 minutes ago Edenred achieves CDP “A” rating and joins the ranks of global leaders in climate action
Published on 04/07/2026 at 08:30, 1 hour 16 minutes ago Edenred obtient la note « A » au CDP et rejoint les leaders mondiaux engagés pour le climat
Published on 04/07/2026 at 08:00, 1 hour 46 minutes ago Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
Published on 04/07/2026 at 08:00, 1 hour 46 minutes ago Un pacte mondial annoncé lors du G7 One Health Summit pour accélérer l'accès aux diagnostics face aux menaces sanitaires croissantes
Published on 04/06/2026 at 15:00, 18 hours 46 minutes ago FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
